Cargando…

Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging

Insights regarding the biodistribution and homing of mesenchymal stromal cells (MSCs), as well as their interaction with alloreactive T-cells are critical for understanding how MSCs can regulate graft-versus-host disease (GVHD) following allogeneic (allo) bone marrow transplantation (BMT). We develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wuttisarnwattana, Patiwet, Eid, Saada, Wilson, David L., Cooke, Kenneth R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886911/ https://www.ncbi.nlm.nih.gov/pubmed/36717650 http://dx.doi.org/10.1038/s41598-023-28478-3

Ejemplares similares

Author Correction: Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
por: Wuttisarnwattana, Patiwet, et al.
Publicado: (2023)

Optimal slice thickness for improved accuracy of quantitative analysis of fluorescent cell and microsphere distribution in cryo-images
por: Wuttisarnwattana, Patiwet, et al.
Publicado: (2023)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021)

Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
por: Dunavin, Neil, et al.
Publicado: (2017)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020)

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019)

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
por: Jaing, Tang-Her, et al.
Publicado: (2023)

Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
por: McGuirk, Joseph P., et al.
Publicado: (2015)

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2020)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022)

Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease
por: Donadel, Camila Derminio, et al.
Publicado: (2023)

Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation
por: Wang, Fangjing, et al.
Publicado: (2015)

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study
por: Kuzmina, Larisa A., et al.
Publicado: (2012)

Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival
por: Galleu, Antonio, et al.
Publicado: (2019)

Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice
por: Vacaru, Andrei Mircea, et al.
Publicado: (2022)

Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease
por: Lin, Yan, et al.
Publicado: (2023)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model
por: Hervás-Salcedo, Rosario, et al.
Publicado: (2023)

Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease
por: Corbett, Jennifer M., et al.
Publicado: (2021)

Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models
por: Robles, Joseph Delano, et al.
Publicado: (2015)

Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019)

Immunosuppressive Effects of Multipotent Mesenchymal Stromal Cells on Graft-Versus-Host Disease in Rats Following Allogeneic Bone Marrow Transplantation
por: Nevruz, Oral, et al.
Publicado: (2013)

Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients
por: Hinden, Liad, et al.
Publicado: (2019)

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
por: Krüger, Thomas, et al.
Publicado: (2022)

Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands
por: Hackel, Alexander, et al.
Publicado: (2023)

Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling
por: Gavin, Caroline, et al.
Publicado: (2019)

Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience
por: Macías-Sánchez, María del Mar, et al.
Publicado: (2022)

Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice
por: Wu, Stanley Chun Ming, et al.
Publicado: (2023)

Mouse models of graft-versus-host disease: advances and limitations
por: Schroeder, Mark A., et al.
Publicado: (2011)

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020)

Therapeutic effects of hydrogen on chronic graft‐versus‐host disease
por: Qian, Liren, et al.
Publicado: (2017)

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
por: Bader, Peter, et al.
Publicado: (2018)

Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft Versus Host Disease
por: Chinnadurai, Raghavan, et al.
Publicado: (2021)

Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018)

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
por: Trento, Cristina, et al.
Publicado: (2018)

Human placental mesenchymal stromal cell‐derived exosome‐enriched extracellular vesicles for chronic cutaneous graft‐versus‐host disease: A case report
por: Norooznezhad, Amir Hossein, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5vgn3i4a4lgd5cn678c69npi9